Shiori Takeji, Mai Okada, Shu Hayashi, Kengo Kanamaru, Yuichi Uno, Hiromasa Imaishi, Tomohide Uno. Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants. Biopharmaceutics & Drug Disposition. 2023. 44. 6. 420-430
Hiroki Kuwada, Kohei Ihara, Hiromasa Imaishi. Development of a new assay system for bladder cancer using interactions between cytochromes P450 and serum. Drug Metabolism and Pharmacokinetics. 2022. 47. 100472-100472
Yasuhiro Yonezuka, Hiroki Kuwada, Hiromasa Imaishi. Diagnosis of drug-induced liver injury in model mice by studying the inhibitory effect of serum components on P450 inhibition assay. Chemico-Biological Interactions. 2022. 365. 110075-110075
Kohei Ihara, Ami Oguro, Hiromasa Imaishi. Diagnosis of Parkinson's disease by investigating the inhibitory effect of serum components on P450 inhibition assay. Scientific Reports. 2022. 12. 1. 6622-6622
Ami Oguro, Yasuhiro Ishihara, Ferbian Milas Siswanto, Takeshi Yamazaki, Atsuhiko Ishida, Hiromasa Imaishi, Susumu Imaoka. Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson’s disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2020. 158858-158858